Department of Cardiology and Angiology, University of Erlangen-Nuremberg, Erlangen, Germany.
Atherosclerosis. 2011 Dec;219(2):499-509. doi: 10.1016/j.atherosclerosis.2011.09.045. Epub 2011 Oct 4.
Vascular endothelial growth factor receptor 2 (VEGFR2), a tyrosine kinase receptor activated by VEGF and shear stress, is critically involved in endothelial mechanotransduction. We investigated the role of VEGFR2 in non-uniform shear stress-induced endothelial susceptibility to inflammatory stimuli.
Endothelial cells (ECs) were exposed to non-uniform shear stress, followed by stimulation with TNF-α. ECs were transfected with siRNAs against VEGFR2. Alternatively, ECs were treated with blocking antibody against VEGFR2, or with inhibitors of VEGFR2 (ZM 323881), PI3K (LY 294002), or Src-kinase (PP2). THP-1 monocytes were used for dynamic adhesion assays. Endothelial protein expression was determined by immunofluorescence.
siRNA against VEGFR2 decreased VEGFR2 protein expression by 40% as determined by Western blotting. In endothelial cells exposed to non-uniform shear stress, VEGFR2 knockdown inhibited TNF-α-induced NF-κB translocation to the nucleus, and the upregulation of VCAM-1 and E-selectin. Consequently, monocytic cell recruitment to endothelium under non-uniform shear stress conditions was reduced. Similar effects were observed by blocking VEGFR2 activity using a specific inhibitor ZM 323881, or an antibody against VEGFR2 before TNF-α stimulation. Inhibition of PI3K with LY 294002 significantly reduced non-uniform shear stress-induced endothelial susceptibility to TNF-α, whereas blocking Src-kinase with PP2 was ineffective.
VEGFR2 is critically involved in adhesion molecule induction and monocytic cell recruitment to endothelium in response to non-uniform shear stress and TNF-α. Targeting the mechanosensory cascade can prevent endothelial activation in atherosclerosis-prone regions.
血管内皮生长因子受体 2(VEGFR2)是一种酪氨酸激酶受体,可被 VEGF 和切应力激活,在血管内皮细胞的机械转导中起着关键作用。本研究旨在探讨 VEGFR2 在非均匀切应力诱导的内皮细胞对炎症刺激的易感性中的作用。
将内皮细胞(ECs)暴露于非均匀切应力下,然后用 TNF-α刺激。用 VEGFR2 的 siRNA 转染 ECs。或者,用 VEGFR2 阻断抗体、VEGFR2 抑制剂(ZM 323881)、PI3K 抑制剂(LY 294002)或 Src 激酶抑制剂(PP2)处理 ECs。使用单核细胞 THP-1 进行动态黏附实验。通过免疫荧光法测定内皮细胞蛋白表达。
Western blot 检测表明,siRNA 可使 VEGFR2 蛋白表达降低 40%。在暴露于非均匀切应力的内皮细胞中,VEGFR2 敲低抑制了 TNF-α诱导的 NF-κB 向核内转移以及 VCAM-1 和 E-选择素的上调。因此,单核细胞在非均匀切应力条件下向内皮细胞的募集减少。用特异性抑制剂 ZM 323881 或在 TNF-α 刺激前用 VEGFR2 抗体阻断 VEGFR2 活性也观察到类似的效果。用 LY 294002 抑制 PI3K 可显著降低非均匀切应力诱导的内皮细胞对 TNF-α的易感性,而用 PP2 阻断 Src 激酶则无效。
VEGFR2 在内皮细胞对非均匀切应力和 TNF-α的黏附分子诱导和单核细胞募集反应中起着关键作用。针对机械感觉级联反应可以预防动脉粥样硬化易发生区域的内皮细胞激活。